Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion.
Saved in:
| Title: | Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion. |
|---|---|
| Authors: | Hedman, Christina A.1,2, Frystyk, Jan3,4, Lindström, Torbjörn1,2, Oskarsson, Per5, Arnqvist, Hans J.2,6 |
| Source: | Clinical Endocrinology. Jul2014, Vol. 81 Issue 1, p58-62. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 03000664 |
|---|---|
| DOI: | 10.1111/cen.12296 |
